Showing results (31-40 of 58) with videos related to

Sort By:
Pageof 6
JNCI Cancer Spectrum|February 8, 2021
Rates of COVID-19-Related Outcomes in Cancer Compared With Noncancer PatientsLova Sun, Sanjna Surya, Anh N Le, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|December 15, 2021
Performance of polygenic risk scores for cancer prediction in a racially diverse academic biobankLouise Wang, Heena Desai, Shefali S Verma, et al.
The British Journal of Radiology|October 11, 2019
Risk of post-operative, pre-radiotherapy contralateral neck recurrence in patients treated with surgery followed by adjuvant radiotherapy for human papilloma virus-associated tonsil cancerJared Gershowitz, Hann-Hsiang Chao, Abigail Doucette, et al.
The Oncologist|June 6, 2022
Moderate Colitis Not Requiring Intravenous Steroids Is Associated with Improved Survival in Stage IV Melanoma after Anti-CTLA4 Monotherapy, But Not Combination TherapyEmily J Anstadt, Brian Chu, Nikhil Yegya-Raman, et al.
JCO Clinical Cancer Informatics|August 28, 2023
Development of an Electronic Health Record-Based Clinical Decision Support Tool for Patients With Lynch SyndromeKelsey S Lau-Min, Joseph Bleznuck, Colin Wollack, et al.
JCO Precision Oncology|August 3, 2023
Biallelic BRCA Loss and Homologous Recombination Deficiency in Nonbreast/Ovarian Tumors in Germline BRCA1/2 CarriersDylane Wineland, Anh N Le, Ryan Hausler, et al.
International Journal of Radiation Oncology, Biology, Physics|October 22, 2023
Patterns of Failure, Low-Volume Relapse, and Subsequent Ablative Management in Locally Advanced Non-Small Cell Lung Cancer Treated With Definitive Chemoradiation and Consolidation Immune Checkpoint InhibitorsCole Friedes, Michelle Iocolano, Sang Ho Lee, et al.
JCO Precision Oncology|August 7, 2025
Implementation of DPYD and UGT1A1 Testing in Patients With GI Cancer: A Prospective, Nonrandomized Clinical TrialSony Tuteja, Mari Angelica S Cayabyab, Glenda Hoffecker, et al.
Clinical Lung Cancer|October 20, 2018
Five-year Long-term Outcomes of Stereotactic Body Radiation Therapy for Operable Versus Medically Inoperable Stage I Non-small-cell Lung Cancer: Analysis by Operability, Fractionation Regimen, Tumor Size, and Tumor LocationCaitlin A Schonewolf, Marina Heskel, Abigail Doucette, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 26, 2023
The effective radiation dose to immune cells predicts lymphopenia and inferior cancer control in locally advanced NSCLCCole Friedes, Michelle Iocolano, Sang Ho Lee, et al.
Pageof 6